Scleritis after proton therapy in uveal melanoma

Klin Monbl Augenheilkd. 2012 Apr;229(4):395-8. doi: 10.1055/s-0031-1299184. Epub 2012 Apr 11.

Abstract

Background: Sclera is a very radioresistant tissue and scleritis after proton therapy has not been described so far.

History and signs: Four female patients, aged between 31 and 74 years, were treated with proton therapy for uveal melanoma (height range: 2.2 - 3.5 mm), located in the macula, the superior equator and 2 in the ciliary body. All patients had a history of a previous or active inflammatory disease and developed scleritis after radiotherapy.

Therapy and outcome: Two patients had infectious scleritis and were treated with adequate antibiotic therapy. After systemic corticotherapy, 3 patients recovered completely; the remaining patient was managed with additional immunosuppressive treatment as well as a conjunctival and scleral graft, but has not become pain free yet.

Conclusion: Scleritis is a possible complication after proton therapy, probably on an ischemic basis, where there is a predisposing factor such as inflammatory systemic disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Melanoma / complications
  • Melanoma / radiotherapy*
  • Middle Aged
  • Neoplasms, Radiation-Induced / diagnosis*
  • Neoplasms, Radiation-Induced / etiology*
  • Neoplasms, Radiation-Induced / surgery
  • Protons / adverse effects*
  • Radiotherapy, Conformal / adverse effects
  • Scleritis / diagnosis*
  • Scleritis / etiology*
  • Scleritis / surgery
  • Treatment Outcome
  • Uveal Neoplasms / complications
  • Uveal Neoplasms / radiotherapy*

Substances

  • Protons